Soluble TNF Mediates the Transition from Pulmonary Inflammation to Fibrosis
Nikos Oikonomou(Alexander Fleming Biomedical Sciences Research Center), Vassilis Aidinis(Alexander Fleming Biomedical Sciences Research Center), George Kollias(National and Kapodistrian University of Athens), Αnastasia Kotanidou(National and Kapodistrian University of Athens), Christos Valavanis(Metaxa Hospital), Jonathan Zalevsky(Nektar Therapeutics (United States)), Vaggelis Harokopos(Alexander Fleming Biomedical Sciences Research Center), David E. Szymkowski(Xencor (United States))
Cited by 136
Related Papers
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
|The Journal of Cell Biology|2000|816
Enhanced antibody half-life improves in vivo activity
|Nature Biotechnology|2010|654
Fibroblasts as immune regulators in infection, inflammation and cancer
|Nature reviews. Immunology|2021|597
JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
|Journal of Biological Chemistry|2005|403